O	0	3	FAS	FAS	NN	B-NP
O	4	5	-	-	HYPH	I-NP
O	5	9	1377	1377	CD	I-NP
O	10	11	G	G	NN	I-NP
O	11	12	/	/	SYM	B-NP
O	12	13	A	A	NN	I-NP
O	14	26	polymorphism	polymorphism	NN	I-NP
O	27	30	and	and	CC	O
O	31	34	the	the	DT	B-NP
O	35	39	risk	risk	NN	I-NP
O	40	42	of	of	IN	B-PP
B-Multi-tissue_structure	43	48	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	49	53	node	node	NN	I-NP
O	54	64	metastasis	metastasis	NN	I-NP
O	65	67	in	in	IN	B-PP
B-Cancer	68	76	cervical	cervical	JJ	B-NP
I-Cancer	77	83	cancer	cancer	NN	I-NP
O	83	84	.	.	.	O

O	86	92	Single	Single	JJ	B-NP
O	92	93	-	-	HYPH	I-NP
O	93	103	nucleotide	nucleotide	NN	I-NP
O	104	117	polymorphisms	polymorphism	NNS	I-NP
O	118	120	of	of	IN	B-PP
O	121	124	the	the	DT	B-NP
O	125	128	FAS	FAS	NN	I-NP
O	129	130	-	-	HYPH	B-NP
O	130	135	1377G	1377G	NN	I-NP
O	135	136	/	/	SYM	I-NP
O	136	137	A	A	NN	I-NP
O	137	138	,	,	,	O
O	139	142	FAS	FAS	NN	B-NP
O	143	144	-	-	HYPH	I-NP
O	144	148	670A	670A	NN	I-NP
O	148	149	/	/	SYM	I-NP
O	149	150	G	G	NN	I-NP
O	150	151	,	,	,	O
O	152	155	and	and	CC	O
O	156	160	FASL	FASL	NN	B-NP
O	161	162	-	-	HYPH	I-NP
O	162	166	844T	844T	NN	I-NP
O	166	167	/	/	SYM	I-NP
O	167	168	C	C	NN	I-NP
O	169	174	genes	gene	NNS	I-NP
O	175	178	may	may	MD	B-VP
O	179	184	alter	alter	VB	I-VP
O	185	200	transcriptional	transcriptional	JJ	B-NP
O	201	209	activity	activity	NN	I-NP
O	210	212	of	of	IN	B-PP
O	213	218	these	these	DT	B-NP
O	219	224	genes	gene	NNS	I-NP
O	224	225	.	.	.	O

O	226	232	Recent	Recent	JJ	B-NP
O	233	241	evidence	evidence	NN	I-NP
O	242	250	suggests	suggest	VBZ	B-VP
O	251	253	an	an	DT	B-NP
O	254	265	association	association	NN	I-NP
O	266	268	of	of	IN	B-PP
O	269	274	these	these	DT	B-NP
O	275	288	polymorphisms	polymorphism	NNS	I-NP
O	289	293	with	with	IN	B-PP
O	294	296	an	an	DT	B-NP
O	297	306	increased	increase	VBN	I-NP
O	307	311	risk	risk	NN	I-NP
O	312	314	of	of	IN	B-PP
B-Cancer	315	323	cervical	cervical	JJ	B-NP
I-Cancer	324	330	cancer	cancer	NN	I-NP
O	330	331	,	,	,	O
O	332	334	so	so	IN	O
O	335	337	we	we	PRP	B-NP
O	338	346	explored	explore	VBD	B-VP
O	347	351	this	this	DT	B-NP
O	352	364	relationship	relationship	NN	I-NP
O	364	365	.	.	.	O

O	366	375	Genotypes	Genotype	NNS	B-NP
O	376	378	of	of	IN	B-PP
O	379	382	155	155	CD	B-NP
O	383	391	patients	patient	NNS	I-NP
O	392	396	with	with	IN	B-PP
B-Cancer	397	405	cervical	cervical	JJ	B-NP
I-Cancer	406	412	cancer	cancer	NN	I-NP
O	413	416	and	and	CC	O
O	417	420	160	160	CD	B-NP
O	421	428	healthy	healthy	JJ	I-NP
O	429	436	control	control	JJ	I-NP
O	437	445	subjects	subject	NNS	I-NP
O	446	450	were	be	VBD	B-VP
O	451	461	determined	determine	VBN	I-VP
O	462	467	using	use	VBG	B-VP
O	468	478	polymerase	polymerase	NN	B-NP
O	479	484	chain	chain	NN	I-NP
O	485	493	reaction	reaction	NN	I-NP
O	493	494	-	-	HYPH	B-VP
O	494	499	based	base	VBN	B-NP
O	500	511	restriction	restriction	NN	I-NP
O	512	520	fragment	fragment	NN	I-NP
O	521	527	length	length	NN	I-NP
O	528	540	polymorphism	polymorphism	NN	I-NP
O	541	542	(	(	(	O
O	542	545	PCR	PCR	NN	B-NP
O	545	546	-	-	HYPH	B-NP
O	546	550	RFLP	RFLP	NN	I-NP
O	550	551	)	)	)	O
O	551	552	.	.	.	O

O	553	565	Associations	Association	NNS	B-NP
O	566	570	with	with	IN	B-PP
B-Cancer	571	577	cancer	cancer	NN	B-NP
O	578	582	risk	risk	NN	I-NP
O	583	587	were	be	VBD	B-VP
O	588	597	estimated	estimate	VBN	I-VP
O	598	603	using	use	VBG	B-VP
O	604	607	two	two	CD	B-NP
O	607	608	-	-	HYPH	I-NP
O	608	613	sided	sided	JJ	I-NP
O	614	622	logistic	logistic	JJ	I-NP
O	623	633	regression	regression	NN	I-NP
O	633	634	.	.	.	O

O	635	637	We	We	PRP	B-NP
O	638	646	observed	observe	VBD	B-VP
O	647	648	a	a	DT	B-NP
O	649	662	significantly	significantly	RB	I-NP
O	663	672	increased	increase	VBN	I-NP
O	673	677	risk	risk	NN	I-NP
O	678	680	of	of	IN	B-PP
B-Multi-tissue_structure	681	686	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	687	691	node	node	NN	I-NP
O	692	702	metastasis	metastasis	NN	I-NP
O	703	713	associated	associate	VBN	B-VP
O	714	718	with	with	IN	B-PP
O	719	722	the	the	DT	B-NP
O	723	726	FAS	FAS	NN	I-NP
O	727	728	-	-	HYPH	O
O	728	732	1377	1377	CD	B-NP
O	733	735	GA	GA	NN	I-NP
O	736	738	or	or	CC	O
O	739	741	AA	AA	NN	B-NP
O	742	754	polymorphism	polymorphism	NN	I-NP
O	755	756	[	[	(	O
O	756	760	odds	odd	NNS	B-NP
O	761	766	ratio	ratio	NN	I-NP
O	767	768	(	(	(	O
O	768	770	OR	OR	NN	B-NP
O	770	771	)	)	)	O
O	772	773	=	=	SYM	B-VP
O	774	775	4	4	CD	B-NP
O	775	776	.	.	.	O
O	776	778	16	16	CD	B-NP
O	778	779	,	,	,	O
O	780	782	95	95	CD	B-NP
O	782	783	%	%	NN	I-NP
O	784	794	confidence	confidence	NN	I-NP
O	795	803	interval	interval	NN	I-NP
O	804	805	(	(	(	O
O	805	807	CI	CI	NN	B-NP
O	807	808	)	)	)	O
O	809	810	=	=	SYM	B-NP
O	811	812	1	1	CD	I-NP
O	812	813	.	.	SYM	I-NP
O	813	815	10	10	CD	I-NP
O	816	818	to	to	TO	I-NP
O	819	821	15	15	CD	I-NP
O	821	822	.	.	.	I-NP
O	822	824	74	74	CD	I-NP
O	824	825	;	;	:	O
O	826	827	P	P	NN	B-NP
O	828	829	=	=	SYM	B-VP
O	830	831	0	0	CD	B-NP
O	831	832	.	.	SYM	I-NP
O	832	835	036	036	CD	I-NP
O	835	836	]	]	)	O
O	836	837	.	.	.	O

O	838	840	In	In	IN	B-PP
O	841	849	addition	addition	NN	B-NP
O	849	850	,	,	,	O
O	851	854	the	the	DT	B-NP
O	855	858	FAS	FAS	NN	I-NP
O	859	860	-	-	HYPH	B-NP
O	860	865	670AG	670AG	NN	I-NP
O	866	868	or	or	CC	I-NP
O	869	871	GG	GG	NN	I-NP
O	872	880	genotype	genotype	NN	I-NP
O	881	887	showed	show	VBD	B-VP
O	888	890	an	an	DT	B-NP
O	891	900	increased	increase	VBN	I-NP
O	901	910	incidence	incidence	NN	I-NP
O	911	913	of	of	IN	B-PP
B-Multi-tissue_structure	914	918	node	node	NN	B-NP
O	919	929	metastasis	metastasis	NN	I-NP
O	929	930	,	,	,	O
O	931	934	but	but	CC	O
O	935	940	these	these	DT	B-NP
O	941	949	findings	finding	NNS	I-NP
O	950	954	were	be	VBD	B-VP
O	955	958	not	not	RB	O
O	959	972	statistically	statistically	RB	B-ADJP
O	973	984	significant	significant	JJ	I-ADJP
O	985	986	(	(	(	O
O	986	988	OR	OR	NN	B-NP
O	989	990	=	=	SYM	B-VP
O	991	992	3	3	CD	B-NP
O	992	993	.	.	SYM	I-NP
O	993	995	67	67	CD	I-NP
O	995	996	,	,	,	I-NP
O	997	999	95	95	CD	I-NP
O	999	1000	%	%	NN	I-NP
O	1001	1003	CI	CI	NN	I-NP
O	1004	1005	=	=	SYM	B-VP
O	1006	1007	0	0	CD	B-NP
O	1007	1008	.	.	.	O
O	1008	1010	96	96	CD	B-NP
O	1010	1011	-	-	:	O
O	1011	1013	14	14	CD	B-NP
O	1013	1014	.	.	.	O
O	1014	1016	00	00	CD	B-NP
O	1016	1017	,	,	,	O
O	1018	1019	P	P	NN	B-NP
O	1020	1021	=	=	SYM	B-VP
O	1022	1023	0	0	CD	B-NP
O	1023	1024	.	.	SYM	I-NP
O	1024	1027	059	059	CD	I-NP
O	1027	1028	)	)	)	O
O	1028	1029	.	.	.	O

O	1030	1035	There	There	EX	B-NP
O	1036	1039	was	be	VBD	B-VP
O	1040	1042	no	no	DT	B-NP
O	1043	1054	significant	significant	JJ	I-NP
O	1055	1066	association	association	NN	I-NP
O	1067	1074	between	between	IN	B-PP
O	1075	1077	an	an	DT	B-NP
O	1078	1087	increased	increase	VBN	I-NP
O	1088	1092	risk	risk	NN	I-NP
O	1093	1095	of	of	IN	B-PP
B-Cancer	1096	1104	cervical	cervical	JJ	B-NP
I-Cancer	1105	1111	cancer	cancer	NN	I-NP
O	1112	1115	and	and	CC	O
O	1116	1129	polymorphisms	polymorphism	NNS	B-NP
O	1130	1132	of	of	IN	B-PP
O	1133	1136	the	the	DT	B-NP
O	1137	1142	death	death	NN	I-NP
O	1143	1150	pathway	pathway	NN	I-NP
O	1151	1156	genes	gene	NNS	I-NP
O	1157	1160	FAS	FAS	NN	I-NP
O	1161	1164	and	and	CC	I-NP
O	1165	1169	FASL	FASL	NN	I-NP
O	1169	1170	.	.	.	O

O	1171	1175	None	None	NN	B-NP
O	1176	1178	of	of	IN	B-PP
O	1179	1182	the	the	DT	B-NP
O	1183	1196	polymorphisms	polymorphism	NNS	I-NP
O	1197	1201	were	be	VBD	B-VP
O	1202	1212	associated	associate	VBN	I-VP
O	1213	1217	with	with	IN	B-PP
O	1218	1222	risk	risk	NN	B-NP
O	1223	1225	of	of	IN	B-PP
O	1226	1234	advanced	advance	VBN	B-NP
O	1235	1240	stage	stage	NN	I-NP
O	1241	1243	or	or	CC	I-NP
O	1244	1254	histologic	histologic	JJ	I-NP
O	1255	1262	subtype	subtype	NN	I-NP
O	1263	1265	of	of	IN	B-PP
B-Cancer	1266	1274	cervical	cervical	JJ	B-NP
I-Cancer	1275	1281	cancer	cancer	NN	I-NP
O	1281	1282	.	.	.	O

O	1283	1285	In	In	IN	B-PP
O	1286	1296	conclusion	conclusion	NN	B-NP
O	1296	1297	,	,	,	O
O	1298	1301	FAS	FAS	NN	B-NP
O	1302	1303	-	-	HYPH	O
O	1303	1307	1377	1377	CD	B-NP
O	1308	1309	G	G	NN	I-NP
O	1309	1310	-	-	SYM	B-NP
O	1310	1311	-	-	HYPH	B-VP
O	1311	1312	>	>	SYM	B-NP
O	1312	1313	A	A	DT	B-NP
O	1314	1326	polymorphism	polymorphism	NN	I-NP
O	1327	1330	may	may	MD	B-VP
O	1331	1333	be	be	VB	I-VP
O	1334	1344	associated	associate	VBN	I-VP
O	1345	1349	with	with	IN	B-PP
O	1350	1352	an	an	DT	B-NP
O	1353	1362	increased	increase	VBN	I-NP
O	1363	1367	risk	risk	NN	I-NP
O	1368	1370	of	of	IN	B-PP
B-Multi-tissue_structure	1371	1376	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1377	1381	node	node	NN	I-NP
O	1382	1392	metastasis	metastasis	NN	I-NP
O	1393	1395	in	in	IN	B-PP
O	1396	1402	Korean	Korean	JJ	B-NP
B-Cancer	1403	1411	cervical	cervical	JJ	I-NP
I-Cancer	1412	1418	cancer	cancer	NN	I-NP
O	1419	1427	patients	patient	NNS	I-NP
O	1427	1428	.	.	.	O

